ÂÜÀòÂÒÂ×

Valarie Truax is a seasoned professional in business development and corporate strategy, most recently serving as Vice President at Reverie Labs from January 2023 to February 2024, following its acquisition by Ginkgo. Prior experience includes Associate Director of Business Development at Nimbus Therapeutics from 2019 to 2022, and a Business Development Associate role at Yale Ventures from 2016 to 2019. Valarie's foundational work includes a postdoctoral fellowship at Bristol Myers Squibb/Emory University (2014-2016) and an associate position at Madison Keats. Educational credentials include an MBA in Finance from Emory University's Goizueta Business School, a PhD in Chemistry from Emory University Laney Graduate School, an MS in Biochemistry and Molecular Biology from Georgetown University, and a BS in Biology from Salem College.